Vivos Therapeutics shares are trading higher after the company announced that it received a notice of allowance for its U.S. patent application 17/522,740 titled "Vibrational Oral Appliance With Mandibular Advancements (To Provide Relief From Sleep Disordered Breathing, Sleep Apnea And/Or Snoring)"
Benzinga Newsdesk - Apr 4, 2024, 12:01PM